Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
ZimVie Inc. - Common Stock
(NQ:
ZIMV
)
16.77
+0.05 (+0.30%)
Streaming Delayed Price
Updated: 12:24 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ZimVie Inc. - Common Stock
< Previous
1
2
Next >
ZimVie to Participate in Upcoming Investor Conferences
May 16, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports First Quarter 2024 Financial Results
May 08, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report First Quarter Financial Results on May 8, 2024
April 24, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Closing of Sale of Spine Business
April 01, 2024
Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Participate in the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
February 21, 2024
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Launch of Next-Generation TSX® Implant in Japan
February 07, 2024
Newest implant innovation is designed for immediacy and peri-implant health
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million
December 18, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation
December 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
November 01, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc
October 31, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT
October 24, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions
October 17, 2023
New offerings expand ZimVie’s dental solutions for lab customers, enhancing selection and broadening the reach of the ZimVie portfolio
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023
October 11, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane
October 10, 2023
New offering broadens ZimVie’s dental portfolio into the expanding growth factor biomaterials market
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
September 26, 2023
Decision clears the way for enrollment of U.S. patients in a groundbreaking clinical study of cervical arthroplasty adjacent to fusion
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
August 17, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces FDA Approval for New Mobi-C® Implant
August 10, 2023
Smaller height implants in all Mobi-C footprints to address patient anatomy
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
August 02, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023
July 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Present at the Stifel 2023 Jaws & Paws Conference
May 22, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance
May 03, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida
April 27, 2023
Modernized 11,000 sq. ft. facility equipped for hands-on dental education and training underscores company’s commitment to lead the industry in advancing professional development of dental...
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug
April 13, 2023
New offerings in ZimVie’s extensive portfolio of dental bone graft solutions enhance selection for customers and bolster cadence of recent product launches
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023
April 12, 2023
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®
April 03, 2023
Mobi-C obtains French government reimbursement and the highest quality rating from the British clinical data panel ODEP
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
March 23, 2023
Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to...
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering
March 15, 2023
The Tether™ device now deemed “medically necessary” for the treatment of pediatric scoliosis in additional patients covered by Highmark and BCBS North Dakota
From
ZimVie Inc.
Via
GlobeNewswire
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
March 01, 2023
From
ZimVie Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.